News

Under the terms of the agreement, Eczacibasi Ilac Pazarlama (EIP) will purchase the product from Pharming and market, sell and distribute it in Turkey. EIP will also pay

This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company’s leading anti-cancer agent, Rexin-G. Administered clinically by simple intravenous infusion,

Mr Emerson was most recently president and CEO of American Medical Systems. He will be replacing Chen Barir, who will continue to serve on the Galil Medical board

However, the analysis of the unblinded primary endpoint data did not show the required level of statistical significance when comparing the SinuNase arm to the control arm. The

Lucid’s VivaScope reflective confocal microscopes provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin

Sam Owusu-Akyaw, president and CEO of Osteotech, said: “The ‘146 patent is an important part of our strategic vision providing patent protection for certain of our current Grafton

The safety data from this interim analysis suggest that the drug was well-tolerated with no serious adverse events reported in heart failure patients exposed to the intended range

LDR began enrolling patients in the first concurrent one and two-level cervical artificial disc study in April of 2006, following nearly two years of clinical experience outside the

The therapeutic areas included in these awards are infectious diseases, immunology/vaccines, cardiovascular diseases, dermatology, and metabolic disorders. Services to be provided include project management, field monitoring, medical monitoring/writing,